SCHEMBL7983505

SCHEMBL7983505

CC(=O)N([C@H](CC(=O)O)c1cccc(Oc2ccccc2)c1)N1C(=O)N[C@](C)(c2ccc(C(=N)N)cc2)C1=O

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.52
ITGA2B P08514 4/20 0.52
ALOX5 P09917 1/20 0.36
F10 P00742 5/20 0.35
F2 P00734 3/20 0.35
FURIN P09958 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 3/20 0.35
F7 P08709 2/20 0.34
PLAU P00749 1/20 0.34
MEN1 O00255 1/20 0.34
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969532 0.91 ITGB3 (0.49) ITGB3ITGA2BALOX5F10KMT2A
Hydrochloric Acid SCHEMBL8488362 0.89 ITGB3 (0.56) ITGB3ITGA2BF10CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL8489120 0.89 ITGB3 (0.56) ITGB3ITGA2BF10CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL7969557 0.89 ITGB3 (0.56) ITGB3ITGA2BF10CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL7986512 0.89 ITGB3 (0.56) ITGB3ITGA2BF10CYP3A4CYP2C9
SCHEMBL7983582 0.89 ITGB3 (0.53) ITGB3ITGA2BF10F2CYP3A4
SCHEMBL7449151 0.86 ITGB3 (0.37) ITGB3ITGA2BALOX5KMT2AMEN1
SCHEMBL7986725 0.86 ITGB3 (0.50) ITGB3ITGA2BF10KMT2AF7
SCHEMBL8489046 0.85 ITGB3 (0.52) ITGB3ITGA2BCYP3A4CYP2C9CYP2C19
SCHEMBL7981888 0.84 ITGB3 (0.50) ITGB3ITGA2BCYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191282-B1 DERIVATIVES OF 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING IS USED AS ANTICARCINOGENIC AGENT AND ANTICOAGULANT HOECHST MARION ROUSSEL (DE) 2001-02-20 US disclosed
US-5981492-A ADMINISTERED TO THE PATIENT TO INHIBIT THROMBOCYTE AGGREGATION, THE METASTASIZATION OF CARCINOMA CELLS, THE BINDING OF OSTEOCLASTS TO THE BONE SURFACE, OR FOR THE TREATMENT OF THROMBOSES HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed